Does APALUTAMIDE Cause Prostate cancer metastatic? 57 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Prostate cancer metastatic have been filed in association with APALUTAMIDE (ERLEADA). This represents 0.6% of all adverse event reports for APALUTAMIDE.
57
Reports of Prostate cancer metastatic with APALUTAMIDE
0.6%
of all APALUTAMIDE reports
14
Deaths
8
Hospitalizations
How Dangerous Is Prostate cancer metastatic From APALUTAMIDE?
Of the 57 reports, 14 (24.6%) resulted in death, 8 (14.0%) required hospitalization, and 1 (1.8%) were considered life-threatening.
Is Prostate cancer metastatic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APALUTAMIDE. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does APALUTAMIDE Cause?
Rash (1,117)
Death (1,008)
Fatigue (824)
Hot flush (532)
Product dose omission issue (384)
Diarrhoea (317)
Asthenia (303)
Dizziness (294)
Fall (268)
Off label use (257)
What Other Drugs Cause Prostate cancer metastatic?
LEUPROLIDE (747)
ABIRATERONE (488)
DOCETAXEL (198)
ENZALUTAMIDE (165)
DENOSUMAB (144)
PREDNISONE (139)
RADIUM RA-223 DICHLORIDE (120)
CABAZITAXEL (74)
BICALUTAMIDE (72)
ZOLEDRONIC ACID (71)
Which APALUTAMIDE Alternatives Have Lower Prostate cancer metastatic Risk?
APALUTAMIDE vs APATINIB
APALUTAMIDE vs APIDRA
APALUTAMIDE vs APIDRA SOLOSTAR
APALUTAMIDE vs APIXABAN
APALUTAMIDE vs APLISOL DIAGNOSTIC ANTIGEN